Nascent Biotech, Inc. Developing Therapy with Indications for COVID-19

The focus of the SmallCapsDaily feature was Nascent Biotechs development of a drug therapy, with indications for use against pathogens, like the SARS-CoV-2 virus, which has spread across the globe, resulting in a pandemic with over 1.3 million cases worldwide, of COVID-19.